Xiangya Hospital of Central South University — Biomedical Watch V2

Essais liés10clinical trials

VilleChangshalocalisation

PaysChinalocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07732309

Ouvrir le site du centre

Essais cliniques associés

10

Molécule	Indication / population	Phase	NCT	Titre	Statut
IPG11406	Lupus	Phase 1/2	NCT06717815	Phase IIa Study for IPG11406 in Patients With Lupus Nephritis	COMPLETED
Soticlestat	Épilepsie	Phase 2	NCT03635073	Endymion 1 — A Study of Soticlestat in Adults and Children With Rare Epilepsies	TERMINATED
Soticlestat	Épilepsie	Phase 3	NCT05163314	A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome	TERMINATED
Cizutamig	Lupus	Phase 1	NCT07215663	Clinical Study of Cizutamig in Systemic Lupus Erythematosus	RECRUITING
LY4298445	Lupus	Phase 1	NCT07276958	A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)	RECRUITING
SHR-2173 injection	Myasthénie	Phase 2	NCT07622342	A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis	NOT_YET_RECRUITING
ATG-201	Lupus	Phase 1	NCT07732309	ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Diseases	NOT_YET_RECRUITING
Telitacicept	Myasthénie	Phase 3	NCT06456580	A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)	RECRUITING
Litifilimab	Lupus	Phase 2/3	NCT05531565	AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	ACTIVE_NOT_RECRUITING
RC18 160mg	Myasthénie	Phase 2	NCT04302103	A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis	COMPLETED